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Background: Carotid stenosis and atrial fibrillation (AF) are common causes of 
ischaemic stroke (IS) and transient ischaemic attack (TIA), and require carotid 
endarterectomy (CEA) and anticoagulation respectively to reduce recurrence risk. 
We assessed whether these interventions improve outcome using data from the 
TARDIS trial. 
 
Method: TARDIS assessed one month of intensive antiplatelet therapy versus 
guideline in 3,096 patients with acute non-cardioembolic IS or TIA. Information 
regarding CEA requirement, AF diagnosis, recurrence and functional outcome was 
assessed centrally blinded to treatment assignment. Data are unadjusted odds ratio 
(OR) or mean difference (MD) with 95% confidence interval (CI) relative to no 
AF/CEA. 
 
Results: 118 patients were diagnosed with AF and 84 required a CEA. In 
comparison with others, AF and CEA patients were older (4.2 and 2.4 years 
respectively) and AF patients were more likely to have been enrolled with stroke than 
TIA (p<0.001). AF patients were more likely to have a stroke/TIA recurrence (OR 
2.31, 95% CI 1.30-4.10; 7 before diagnosis, 9 afterwards), and have a shift to more 
dependency (modified Rankin Scale, OR 1.50, 95% CI 1.07-2.10) and disability 
(Barthel Index, MD -6.5, 95% CI -10.0 to -3.1). Outcomes of CEA patients were not 
significantly different from patients who did not require CEA. 
 
Conclusion: Recurrence was more common in patients with AF than in other 
TARDIS patients; patients with AF also had worse functional outcomes. There was 
no difference in recurrence or functional outcomes between patients who did and did 
not require CEA. 
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